European Archives - Page 18 of 1441 - European Medical Journal

Aerial view of Christ the redeemer and Botafogo Bay from high angle.

Fluvoxamine Shows Promise for Long COVID Fatigue

Fluvoxamine may reduce long COVID fatigue and boost quality of life, while metformin shows no benefit in adults with persistent post-COVID symptoms.

Deep Learning Reveals Novel Asthma Risk Variants

Polygenic risk score models derived from variants prioritised by the deep learning framework demonstrated improved predictive performance compared with those based on traditional GWAS approaches.

Sleep Breathing Disorders Linked to Cognitive Impairment in Children

Children with sleep breathing disorders score lower across cognitive domains, highlighting risks for learning and memory deficits, meta-analysis finds.

Novel Biomarkers Predict Survival in Gastric Cancer

CXCL12, a chemokine involved in immune cell trafficking and tumour microenvironment regulation, appeared to be strongly associated with improved survival outcomes.

AI Drug Discovery Platform Launched to Tackle Global Diseases

A new AI platform offers free drug discovery tools to global health researchers, aiming to speed up treatments for malaria, tuberculosis, and more.

Alcohol Underreporting Hides True Liver Disease Risk

Underreported alcohol use masks alcohol-related liver disease, increasing misclassification and obscuring true mortality rates.

AI-Assisted Chest X-Rays in TB Detection Across LMICs

AI-assisted chest X-rays are enhancing TB detection in LMICs, helping clinicians identify cases earlier where imaging access and expertise are limited.

GLP-1s May be Effective Treatments for Mental Illness in Diabetes

Semaglutide is associated with a lower risk of worsening anxiety, depression, and substance use disorder in patients with co-occurring mental illness and diabetes.

Novel Cholesterol Drug Outperforms Existing Treatments

Novel Cholesterol Drug Outperforms Existing Treatments

The oral PCSK9 inhibitor achieved a mean LDL-C reduction of -64.6% from baseline, substantially outperforming bempedoic acid (-6.3%), ezetimibe (-27.8%), and combination therapy (-36.5%).

Novel Acid-Tolerant Bioadhesive for Gastric Perforation

Novel Acid-Tolerant Bioadhesive for Gastric Perforation

Scientists have unveiled a novel injectable acid-tolerant bioadhesive for large gastric perforation.